2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO12] Mini-Oral Session 12　Hematologic Malignancies 2（Lymphoid）
【E】

Thu. Feb 17, 2022 8:30 AM - 9:20 AM Room 9 (Swan, 1F, Kyoto International Conference Center)

Chair：Kenji Ishitsuka（Department of Hematology and Rheumatology, Kagoshima University），Yasushi Takamatsu（Division of Medical Oncology, Hematology and Infectious Diseases, Department of Internal medicine, Fukuoka University）

[MO12-1] Interim Results of Phase 1 study of Zandelisib(ME-401) Monotherapy in Japanese R/R Indolent B-cell non-Hodgkin Lymphoma

○Koji Izutsu1, Hideki Goto2, Daisuke Ennishi3, Yuko Mishima4, Shinichi Makita1, Koji Kato5, Miyoko Hanaya6, Satoshi Hirano6, Kazuya Narushima6, Takanori Teshima2, Hirokazu Nagai7, Kenichi Ishizawa8 (1.National Cancer Center Hospital, 2.Department of Hematology, Hokkaido University Faculty of Medicine, 3.Department of Hematology and Oncology, Okayama University Hospital, 4.Department of Hematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, 5.Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, 6.Kyowa Kirin Co., Ltd., 7.Department of Hematology, National Hospital Organization Nagoya Medical Center, 8.Department of Third Internal Medicine, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password